CORONAVIRUS/Taiwan receives 1,728 Evusheld doses for immunocompromised people
Taipei, Sept. 8 (CNA) Taiwan has purchased 10,000 doses of Evusheld to provide protection to immunocompromised people at high risk of contracting severe COVID-19, with the first shipment of 1,728 doses having already arrived in the country, according to the Central Epidemic Command Center (CECC) Thursday.
The 1,728 doses of Evusheld, a combination of two monoclonal antibodies -- tixagevimab (AZD8895) and cilgavimab (AZD1061) -- developed by AstraZeneca arrived in Taiwan on Tuesday and will be delivered to medical centers and regional hospitals for conditional use starting Thursday, where they will undergo medical evaluation to determine their safety and efficacy, CECC head Victor Wang (王必勝) said.
Evusheld is a preventive antibody therapy that has shown neutralizing activity against the Omicron BA.2, BA.2.12.1, BA.4, and BA.5 subvariants and is authorized for emergency use as a pre-exposure prophylaxis for COVID-19.
The monoclonal antibodies have received emergency use authorization (EUA) in the United States, France, the United Kingdom, Australia and several countries in Europe as a preventive tool for individuals who cannot get vaccinated or immunocompromised patients before they are exposed to COVID-19.
The Centers for Disease Control has included Evusheld as a recommended drug in its guidelines for clinical management of infection from SARS-CoV-2, the coronavirus that causes COVID-19, and the Evusheld doses will be stored in medical centers and some regional hospitals to be used for eligible people, including patients with congenital immunodeficiencies, the CECC said.
However, the CECC noted that timely vaccination against COVID-19 is still the most effective measure for preventing infection, saying that Evusheld cannot replace vaccination.
As of Wednesday, 93.1 percent of the eligible Taiwanese population had received at least one COVID-19 dose, while 87 percent had gotten two shots and 73.3 percent had received a first booster shot.
About 9.8 percent of the population has received a second booster shot, including 34.9 percent of those aged 65 and above, CECC statistics showed.
- CECC eyes broad easing of COVID policies, with mask rules first on docketThe Central Epidemic Command Center (CECC) has begun discussing a widespread easing of Taiwan's COVID-19 policies and will announce plans this week to relax the indoor mask ...01/30/2023 06:31 PM
- New round of COVID-19 rapid test rationing to start Feb. 1The latest round of a government rationing program that allows people to buy cheaper COVID-19 rapid tests will begin on Feb. 1, while free tests will be available to seniors and ...01/30/2023 03:46 PM
- Taiwan reports 22,291 new COVID-19 cases, 30 deathsTaiwan on Monday reported 22,291 new cases of COVID-19 and 30 deaths from the disease, according to the Central Epidemic Command Center (CECC).01/30/2023 03:41 PM
Tsai congratulates Czech president-elect in rare call to non-ally leader01/30/2023 11:07 PM
Thai police admit to possible extortion of Taiwan celeb01/30/2023 10:38 PM
Polish author of 'The Witcher' appears at Taipei book fair event01/30/2023 09:45 PM
Hon Hai hires ex-Nissan, Nidec executive Seki for EV business01/30/2023 09:36 PM
- Science & Tech
84.1-meter Taiwania tree confirmed as Taiwan's tallest01/30/2023 09:27 PM